Objective
Multiple sclerosis (MS) is a chronic inflammatory demyelisation disease of the central nervous system, frequently causing severe disabilities. It is characterised by the infiltration of immunology cells and the presence of large demyelinated plaques. Emerging data involve the matrix metalloproteinases (Mumps) in the pathogenesis of this and other demyelisation diseases. The use of Mumps inhibitors in animal models resulted in promising data, but no one could prevent the onset of the disease. In recent years a dramatic increase in the number of known MMP roles in cellular physiology has been revealed, including demyelisation, and new Mumps are described each year. Thus, a necessary condition prior to optimise the Mumps therapeutics in MS is to systematically characterise these new elements in autoimmune animal models, including temporal and cellular expression patterns, in order to block demyelisation and enhance Dependent-dependent demyelisation. To this end mRNA synthesis, protein expression and enzyme activity of new Dependent will be studied in depth in several autoimmunity animal models, as well as in MS human samples from European brain banks. Once the relevant Dependent would be identified, the effects of their specific inhibition, basically in terms of demyelisation, demyelisation and axonal damage, will be studied. To this end several strategies will be tested, such as specific MMP inhibitors and antisepses oligonucleotides, and a further collaboration with the pharmaceutical industry at this point may be possible. Through this project the applicant expects to succeed in three main points. The first one is to learn new technologies with broad possibilities such as real time PCR or laser capture micro dissection, as well as animal models of MS. The second one is to improve his knowledge in MS itself and in Dependent, as this group of enzymes is being implied in a growing number of neuropathologys, such as MS. Alzheimer's disease or stroke.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences basic medicine neurology dementia alzheimer
- medical and health sciences basic medicine neurology multiple sclerosis
- medical and health sciences basic medicine immunology
- medical and health sciences basic medicine physiology
- medical and health sciences basic medicine neurology stroke
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Data not available
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
40225 DUESSELDORF
Germany
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.